Management's refusal to chase loan volume with looser terms is the real test of whether cost discipline can sustain earnings ...

Architectural specifications and the adoption of electronic locks create multiyear revenue visibility that pricing discipline ...

I'm not ready to call an AI bubble, though there's clearly pressure on stocks like CoreWeave. Still, the evidence shows that ...

As the chart shows, Rigetti's sales multiple is more than six times IonQ's, suggesting the latter is the better value. This, ...

Take IonQ ( IONQ -3.47%) and D-Wave ( QBTS -3.88%), for example. Their share prices are down 29% and 54% year to date, ...

Cancellations now stem from clinical failures rather than funding shortages, signaling a healthier market for contract ...

Tesla (TSLA-3.08%) reported third-quarter results late Wednesday, Oct. 21, and the stock has inched lower since. Shares trade ...

Pricing power and operational discipline held margins steady even as sales flatlined, signaling resilience beyond the current ...

Production ramps create near-term cost pressure, but management sees a clear path to 18% operating margins by decade's end.

Higher charge-offs and lower earnings guidance offset the strategic wins from new funding partnerships and loan retention.

Gross margins hit 64% as industrial and data center demand converged, but capital spending is climbing to nearly $3 billion.

Two of these creatures are Pfizer ( PFE +1.91%) and AbbVie ( ABBV +0.14%). But in an environment of rising interest rates, ...